22.07.2015 Views

Good Health Can’t Wait.

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Corporate Overview Annual Report 2014 - 15<br />

Given that VUR is rare, its treatment<br />

options are few and inconvenient. They<br />

include antibiotics and surgery that<br />

involve long hospital stay and painful<br />

procedures. Not only is this difficult for<br />

children under six, it is also an expensive<br />

proposition.<br />

At Dr. Reddy’s, we believe limited<br />

treatment options should not be a hurdle<br />

to care. Even for rare diseases that affect<br />

only a few people, our aim is to respond<br />

with urgency to offer affordable and<br />

innovative solutions.<br />

A safe, affordable alternative approach to<br />

treating VUR, therefore, became a mission<br />

for us.<br />

Following extensive research and<br />

coordination with multiple teams, we<br />

tied up with Oceana Therapeutics Inc.<br />

to import Deflux®, a minimally invasive<br />

endoscopic injection to treat Grade II-IV<br />

VUR effectively with 80-90% success rate.<br />

It provides a higher level of protection<br />

against infection, compared to antibiotics,<br />

and has an excellent safety profile.<br />

Independent studies also established that<br />

there was nearly a four-fold reduction in<br />

Deflux®<br />

A minimally invasive<br />

endoscopic injection<br />

to treat Grade II-IV<br />

VUR effectively with<br />

80-90% success rate.<br />

VUR associated infections<br />

compared with antibiotics.<br />

It also helps to reduce the<br />

need of invasive surgical<br />

procedure.<br />

Our next step was to make pediatric<br />

surgeons aware of the availability of a<br />

viable therapy and also train them in its<br />

proper use. We organized special crossspecialty<br />

meetings for pediatricians<br />

and pediatric surgeons to inform<br />

doctors of the benefits of<br />

the drug and facilitate<br />

early diagnosis. We<br />

also collaborated with<br />

Olympus (a medical<br />

device company) to<br />

provide pediatric<br />

surgeons with<br />

an expensive<br />

device used for<br />

injecting Deflux®.<br />

As a result, we<br />

have been able<br />

to treat more than<br />

280 children in<br />

India till date.<br />

>280<br />

children in India treated<br />

Dr. Reddy’s tied up with<br />

Oceana Therapeutics Inc.<br />

to import Deflux®.<br />

Small children can now<br />

smile more. VUR can be<br />

effectively managed, as<br />

the treatment is faster, less<br />

painful and more affordable<br />

– an encouraging reality for<br />

doctors and families of the<br />

affected children.<br />

13

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!